Climb Bio, Inc. (CLYM) Tops Q2 EPS by 5c

Climb Bio, Inc. (NASDAQ: CLYM) reported Q2 EPS of ($0.13), $0.05 better than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Climb Bio, Inc. (CLYM) click here.

You May Also Be Interested In

• JPMorgan Starts TIME dotCom Berhad (TDC:MK) at Overweight
• Magnolia Said In Lead To Acquire Wildfire For Over $4 Billion - Bloomberg
• UBS Upgrades Paradise Co (034230:KS) to Buy